BioDelivery Sciences Intl downgraded by HC Wainwright & Co. with a new price target

11/4/21 7:12:11 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. downgraded BioDelivery Sciences Intl from Buy to Neutral and set a new price target of $4.50 from $6.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BDSI

Date	Price Target	Rating	Analyst
2/15/2022	$5.00 → $5.60	Overweight → Neutral	Piper Sandler
1/21/2022	$4.00 → $4.50	Neutral	HC Wainwright & Co.
11/4/2021	$6.00 → $4.50	Buy → Neutral	HC Wainwright & Co.
8/5/2021	$5.50 → $6.00	Buy	HC Wainwright & Co.